ESSEX PROPERTY TRUST, INC. (ESS) Stock

Real EstateREIT - Residential Website

ESS has an Alpha Score of 46 out of 100 (weak), computed on Nov 12, 2026 from 3 of 4 sub-scores. 5 members of Congress disclosed 8 trades in ESS since 2014: 3 purchases and 5 sales, most recently Alan Armstrong (purchase, Mar 27, 2026). 3 of the hedge funds AlphaScala tracks reported ESS in 13F filings for the quarter ended Sep 30, 2026; the largest reported position is Citadel's at $23.92M. Its trailing P/E ratio is 50.6 and its net margin 17.8% (key statistics as of Nov 14, 2026).

$273.32
+0.56%
Last price
Source: Finnhub
Alpha Score
46
Weak

What is ESS's Alpha Score?

How it works →

Alpha Score of 46 reflects weak overall profile with moderate momentum, weak value, weak quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.

Momentum
64
Moderate
Value
50
Weak
Quality
38
Weak

Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.

Computed Nov 12, 2026

A rules-based research rating, not a recommendation to buy or sell.

Which members of Congress traded ESSEX PROPERTY TRUST, INC. (ESS)?

Members
5
Disclosed trades
8
Purchases
3
Sales
5

Most recent: Alan Armstrong (purchase, Mar 27, 2026); records start Aug 27, 2014.

PoliticianTrade dateTypeAmount
Alan Armstrong
R-OK · Senate
2026-03-27purchase$1k – $15k
Rick Larsen
D-WA · House
2026-01-07sale$1k – $15k
Dan Goldman
D-NY · House
2023-07-12sale$15k – $50k
Sheldon Whitehouse
D-RI · Senate
2023-04-18sale$1k – $15k
Rick Larsen
D-WA · House
2022-07-07purchase$1k – $15k
Rick Larsen
D-WA · House
2021-07-07purchase$1k – $15k
Zoe Lofgren
D-CA · House
2020-03-23sale$1k – $15k
Sheldon Whitehouse
D-RI · Senate
2014-08-27partial sale$15k – $50k

From STOCK Act periodic transaction reports. House filings as of Nov 12, 2026. Senate records here end Nov 4, 2026; later Senate trades are not included.

See all ESS political trades →

Which hedge funds own ESS?

From 13F filings
FundShares HeldPosition ValueChange vs prior Q
Citadel
Ken Griffin
82K$23.92M-74%
Marshall Wace13K$3.59MNEW
Millennium Management
Israel Englander
3K$808.0K-96%

13F holdings as of Sep 30, 2026

Explore all tracked funds →

What are ESS's key statistics?

P/E Ratio
50.63
EPS (TTM)
5.39
Dividend Yield
4.30%
Beta
0.70
Net Margin
17.85%
ROE
6.43%
Debt / Equity
1.23
52W High
$303.35
52W Low
$238.46

Key statistics as of Nov 14, 2026

How does ESS's valuation compare with the Real Estate sector?

MetricESSReal Estate medianCompanies in median
P/E ratio50.629.773
Net margin17.85%14.67%80
Return on equity6.43%7.16%82
Dividend yield (payers)4.30%4.47%68

Medians over the Real Estate stocks whose key statistics were refreshed in the last 35 days (newest Nov 16, 2026). P/E excludes loss-making companies.

AlphaScala analysis on ESS

Latest 1

ESS price chart

Powered by TradingView

What does ESSEX PROPERTY TRUST, INC. do?

Essex Property Trust, Inc. is a fully integrated real estate investment trust (REIT) specializing in the multifamily residential sector. It focuses on the ownership, operation, management, acquisition, development, and redevelopment of apartment communities, primarily in supply-constrained West Coast markets including urban and suburban submarkets of Southern California, Northern California, and Seattle. The company maintains ownership interests in approximately 259 apartment communities comprising over 63,000 apartment homes, with additional properties in active development. Essex Property Trust, Inc. emphasizes high-quality, large-scale properties that serve residents in vibrant coastal economies, supporting stable rental housing demand driven by strong job and income growth in these regions. Founded in 1971 and headquartered in San Mateo, California, it plays a key role in providing residential real estate exposure within the REIT industry, catering to investors seeking income-oriented opportunities in premium apartment markets.

CEO
Ms. Angela L. Kleiman
Employees
1,686
Market Cap
$17.58B
Ask about ESSAI research agent